(Q45358708)

13 December 2017

Neutrophil-to-lymphocyte ratio associated with mortality in early hepatocellular carcinoma patients after radiofrequency ablation (English)

1 reference

13 December 2017

hepatocellular carcinoma

1 reference

Tsung-Ming Chen

1

1 reference

13 December 2017

Chun-Che Lin

series ordinal

2

1 reference

13 December 2017

Pi-Teh Huang

series ordinal

3

1 reference

13 December 2017

Chen-Fan Wen

series ordinal

4

1 reference

13 December 2017

1 March 2012

1 reference

Journal of Gastroenterology and Hepatology

13 December 2017

1 reference

13 December 2017

27

1 reference

13 December 2017

3

1 reference

13 December 2017

553-561

1 reference

Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma

13 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06910.X

Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06910.X

Local ablation for hepatocellular carcinoma in Taiwan: different points between Japan, Asia and West

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06910.X

A new prognostic score system in patients with advanced hepatocellular carcinoma not amendable to locoregional therapy: implication for patient selection in systemic therapy trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06910.X

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06910.X

High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06910.X

Predicting survival for diffuse large B-cell lymphoma patients using baseline neutrophil/lymphocyte ratio

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06910.X

The effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06910.X

Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06910.X

Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06910.X

Effect of preoperative neutrophil-lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who do not receive adjuvant chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06910.X

Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06910.X

Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06910.X

Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06910.X

Blood neutrophil-to-lymphocyte ratio predicts survival in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06910.X

Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06910.X

Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06910.X

Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06910.X

p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06910.X

Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06910.X

A simulation study of cross-validation for selecting an optimal cutpoint in univariate survival analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06910.X

Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06910.X

Initial Treatment Response Is Essential to Improve Survival in Patients with Hepatocellular Carcinoma Who Underwent Curative Radiofrequency Ablation Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06910.X

Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06910.X

10.1111/J.1440-1746.2011.06910.X

21 January 2018

Identifiers

DOI

1 reference

13 December 2017

1 reference